HEADER HYDROLASE 06-MAR-96 1GAH TITLE GLUCOAMYLASE-471 COMPLEXED WITH ACARBOSE CAVEAT 1GAH GLC D 1 HAS WRONG CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUCOAMYLASE-471; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 1-471; COMPND 5 SYNONYM: GLUCOAMYLASE-II, GLUCAN 1,4-ALPHA-GLUCOSIDASE; COMPND 6 EC: 3.2.1.3; COMPND 7 OTHER_DETAILS: COMPLEXED WITH ACARBOSE SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ASPERGILLUS AWAMORI; SOURCE 3 ORGANISM_TAXID: 105351; SOURCE 4 VARIANT: X100 KEYWDS HYDROLASE, GLYCOSIDASE, POLYSACCHARIDE DEGRADATION, GLYCOPROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR A.E.ALESHIN,B.STOFFER,L.M.FIRSOV,B.SVENSSON,R.B.HONZATKO REVDAT 6 03-APR-24 1GAH 1 HETSYN REVDAT 5 29-JUL-20 1GAH 1 CAVEAT COMPND REMARK SEQADV REVDAT 5 2 1 HET HETNAM HETSYN FORMUL REVDAT 5 3 1 LINK SITE ATOM REVDAT 4 21-MAR-18 1GAH 1 REMARK REVDAT 3 13-JUL-11 1GAH 1 VERSN REVDAT 2 24-FEB-09 1GAH 1 VERSN REVDAT 1 17-AUG-96 1GAH 0 JRNL AUTH A.E.ALESHIN,B.STOFFER,L.M.FIRSOV,B.SVENSSON,R.B.HONZATKO JRNL TITL CRYSTALLOGRAPHIC COMPLEXES OF GLUCOAMYLASE WITH JRNL TITL 2 MALTOOLIGOSACCHARIDE ANALOGS: RELATIONSHIP OF STEREOCHEMICAL JRNL TITL 3 DISTORTIONS AT THE NONREDUCING END TO THE CATALYTIC JRNL TITL 4 MECHANISM. JRNL REF BIOCHEMISTRY V. 35 8319 1996 JRNL REFN ISSN 0006-2960 JRNL PMID 8679589 JRNL DOI 10.1021/BI960321G REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.E.ALESHIN,C.HOFFMAN,L.M.FIRSOV,R.B.HONZATKO REMARK 1 TITL REFINED CRYSTAL STRUCTURES OF GLUCOAMYLASE FROM ASPERGILLUS REMARK 1 TITL 2 AWAMORI VAR. X100 REMARK 1 REF J.MOL.BIOL. V. 238 575 1994 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 2 REMARK 1 AUTH A.E.ALESHIN,L.M.FIRSOV,R.B.HONZATKO REMARK 1 TITL REFINED STRUCTURE FOR THE COMPLEX OF ACARBOSE WITH REMARK 1 TITL 2 GLUCOAMYLASE FROM ASPERGILLUS AWAMORI VAR. X100 TO 2.4-A REMARK 1 TITL 3 RESOLUTION REMARK 1 REF J.BIOL.CHEM. V. 269 15631 1994 REMARK 1 REFN ISSN 0021-9258 REMARK 1 REFERENCE 3 REMARK 1 AUTH E.M.HARRIS,A.E.ALESHIN,L.M.FIRSOV,R.B.HONZATKO REMARK 1 TITL REFINED STRUCTURE FOR THE COMPLEX OF 1-DEOXYNOJIRIMYCIN WITH REMARK 1 TITL 2 GLUCOAMYLASE FROM ASPERGILLUS AWAMORI VAR. X100 TO 2.4-A REMARK 1 TITL 3 RESOLUTION REMARK 1 REF BIOCHEMISTRY V. 32 1618 1993 REMARK 1 REFN ISSN 0006-2960 REMARK 1 REFERENCE 4 REMARK 1 AUTH A.ALESHIN,A.GOLUBEV,L.M.FIRSOV,R.B.HONZATKO REMARK 1 TITL CRYSTAL STRUCTURE OF GLUCOAMYLASE FROM ASPERGILLUS AWAMORI REMARK 1 TITL 2 VAR. X100 TO 2.2-A RESOLUTION REMARK 1 REF J.BIOL.CHEM. V. 267 19291 1992 REMARK 1 REFN ISSN 0021-9258 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 84.7 REMARK 3 NUMBER OF REFLECTIONS : 34143 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.131 REMARK 3 FREE R VALUE : 0.159 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3569 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 320 REMARK 3 SOLVENT ATOMS : 531 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 14.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.15 REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.350 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.50 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.240 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PARAH3.CHO REMARK 3 PARAMETER FILE 2 : ACR_SUGARS_XPLOR.PAR REMARK 3 PARAMETER FILE 3 : ACR_VLN.PAR REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : NTOPH3.CHO REMARK 3 TOPOLOGY FILE 2 : ACR_SUGARS_XPLOR.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1GAH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000173478. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 293 REMARK 200 PH : 4.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : SIEMENS REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE(002) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : SIEMENS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XENGEN REMARK 200 DATA SCALING SOFTWARE : XENGEN REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 34394 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 15.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 4.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 84.6 REMARK 200 DATA REDUNDANCY : 2.560 REMARK 200 R MERGE (I) : 0.05700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 22.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.13 REMARK 200 COMPLETENESS FOR SHELL (%) : 54.3 REMARK 200 DATA REDUNDANCY IN SHELL : 1.70 REMARK 200 R MERGE FOR SHELL (I) : 0.14500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR 3.1 REMARK 200 STARTING MODEL: NATIVE GLUCOAMYLASE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.03 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.80 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 4.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 58.40000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 24.20000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 52.05000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 24.20000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 58.40000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 52.05000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 GLUCOAMYLASE-471 IS A NATURAL PROTEOLYTIC FRAGMENT OF REMARK 400 PARENT GLUCOAMYLASE, WHICH IS INITIALLY SECRETED BY FUNGI. REMARK 400 GLUCOAMYLASE-471 LACKS THE STARCH-BINDING DOMAIN AND A PART REMARK 400 OF THE O-GLYCOSYLATED LINKER DOMAIN. THE ACTUAL LENGTH OF REMARK 400 GLUCOAMYLASE-471 FROM ASPERGILLUS AWAMORI VAR. X100 IS REMARK 400 NOT DETERMINED EXACTLY. THE CRYSTALLOGRAPHICALLY OBSERVED REMARK 400 LENGTH VARIES BETWEEN 471 AND 473 RESIDUES. REMARK 400 REMARK 400 THE SEQUENCE USED IS THAT OF GLUCOAMYLASE FROM ASPERGILLUS REMARK 400 AWAMORI VAR. KAWACHI (SEE JRNL AND REFERENCE 4). RESIDUE REMARK 400 NUMBERS ARE DISCONTINUOUS. RESIDUE NUMBER 102 IS SKIPPED REMARK 400 SO THAT THE NUMBERING OF THE RESIDUES IS CONSISTENT WITH REMARK 400 GLUCOAMYLASE FROM ASPERGILLUS NIGER. RESIDUE NUMBERS 141, REMARK 400 240, 319, 320, AND 445 HAVE THE AMINO ACID TYPE REMARK 400 CORRESPONDING TO THE GLUCOAMYLASE FROM ASPERGILLUS NIGER, REMARK 400 RATHER THAN THAT OF ASPERGILLUS AWAMORI VAR. KAWACHI. REMARK 400 REMARK 400 THE POLYPEPTIDE CHAIN FOLDS INTO AN ALPHA/ALPHA-BARREL, REMARK 400 COMPRISING 12 HELICES. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 606 H2 HOH A 637 1.56 REMARK 500 H2 HOH A 638 O HOH A 762 1.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 147 56.82 -109.47 REMARK 500 ILE A 154 -63.31 -107.08 REMARK 500 SER A 208 -152.97 -119.28 REMARK 500 ASN A 313 0.18 83.94 REMARK 500 SER A 411 -157.47 67.19 REMARK 500 ALA A 442 39.99 -144.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 ACARBOSE IS BOUND TO THE ACTIVE SITE OF THE ENZYME. REMARK 600 ACARBOSE IS PSEUDOTETRASACCHARIDE. THE LAST TWO RESIDUES REMARK 600 OF THE REDUCING END PRESENT IN TWO ALTERNATE CONFORMATIONS, REMARK 600 ONE OF WHICH (OCCUPANCY 0.47) CORRESPONDS TO THE REMARK 600 CONFORMATION OF THE INHIBITOR OBSERVED AT PH 6.0. REMARK 600 REMARK 600 SEE RELATED PROTEIN DATA BANK ENTRY 1AGM FOR THE STRUCTURE REMARK 600 OF GLUCOAMYLASE-471 COMPLEXED WITH ACARBOSE DETERMINED REMARK 600 AT PH 6.0. REMARK 600 REMARK 600 SEE RELATED PROTEIN DATA BANK ENTRY 1GAI FOR THE STRUCTURE REMARK 600 OF GLUCOAMYLASE-741 COMPLEXED WITH D-GLUCO-DIHYDROACARBOSE REMARK 600 DETERMINED AT PH 4.0. REMARK 700 REMARK 700 SHEET REMARK 700 MOST OF THE SHEETS FOR GLUCOAMYLASE-471 ARE HAIRPIN LOOPS REMARK 700 THAT CONNECT HELICES. THESE LOOPS HAVE TWO OR MORE H-BONDS REMARK 700 BETWEEN THE ANTIPARALLEL STRANDS THAT COMPRISE THEM. IN REMARK 700 ADDITION INDIVIDUAL LOOPS PACK TOGETHER, BUT THERE EXISTS REMARK 700 GENERALLY ONLY ONE H-BOND BETWEEN A LOOP AND ITS NEIGHBOR. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: SB1 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: BINDING SUBSITE FOR THE FIRST RESIDUE OF REMARK 800 ACARBOSE REMARK 800 REMARK 800 SITE_IDENTIFIER: SB2 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: BINDING SUBSITE FOR THE SECOND RESIDUE OF REMARK 800 ACARBOSE REMARK 800 REMARK 800 SITE_IDENTIFIER: SB3 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: BINDING SUBSITE FOR THE THIRD RESIDUE OF REMARK 800 ACARBOSE DBREF 1GAH A 1 472 UNP P22832 AMYG_ASPSH 25 495 SEQADV 1GAH LEU A 58 UNP P22832 ILE 82 CONFLICT SEQADV 1GAH ILE A 60 UNP P22832 LEU 84 CONFLICT SEQADV 1GAH THR A 117 UNP P22832 ALA 140 CONFLICT SEQRES 1 A 471 ALA THR LEU ASP SER TRP LEU SER ASN GLU ALA THR VAL SEQRES 2 A 471 ALA ARG THR ALA ILE LEU ASN ASN ILE GLY ALA ASP GLY SEQRES 3 A 471 ALA TRP VAL SER GLY ALA ASP SER GLY ILE VAL VAL ALA SEQRES 4 A 471 SER PRO SER THR ASP ASN PRO ASP TYR PHE TYR THR TRP SEQRES 5 A 471 THR ARG ASP SER GLY LEU VAL ILE LYS THR LEU VAL ASP SEQRES 6 A 471 LEU PHE ARG ASN GLY ASP THR ASP LEU LEU SER THR ILE SEQRES 7 A 471 GLU HIS TYR ILE SER SER GLN ALA ILE ILE GLN GLY VAL SEQRES 8 A 471 SER ASN PRO SER GLY ASP LEU SER SER GLY GLY LEU GLY SEQRES 9 A 471 GLU PRO LYS PHE ASN VAL ASP GLU THR ALA TYR THR GLY SEQRES 10 A 471 SER TRP GLY ARG PRO GLN ARG ASP GLY PRO ALA LEU ARG SEQRES 11 A 471 ALA THR ALA MET ILE GLY PHE GLY GLN TRP LEU LEU ASP SEQRES 12 A 471 ASN GLY TYR THR SER ALA ALA THR GLU ILE VAL TRP PRO SEQRES 13 A 471 LEU VAL ARG ASN ASP LEU SER TYR VAL ALA GLN TYR TRP SEQRES 14 A 471 ASN GLN THR GLY TYR ASP LEU TRP GLU GLU VAL ASN GLY SEQRES 15 A 471 SER SER PHE PHE THR ILE ALA VAL GLN HIS ARG ALA LEU SEQRES 16 A 471 VAL GLU GLY SER ALA PHE ALA THR ALA VAL GLY SER SER SEQRES 17 A 471 CYS SER TRP CYS ASP SER GLN ALA PRO GLN ILE LEU CYS SEQRES 18 A 471 TYR LEU GLN SER PHE TRP THR GLY SER TYR ILE LEU ALA SEQRES 19 A 471 ASN PHE ASP SER SER ARG SER GLY LYS ASP THR ASN THR SEQRES 20 A 471 LEU LEU GLY SER ILE HIS THR PHE ASP PRO GLU ALA GLY SEQRES 21 A 471 CYS ASP ASP SER THR PHE GLN PRO CYS SER PRO ARG ALA SEQRES 22 A 471 LEU ALA ASN HIS LYS GLU VAL VAL ASP SER PHE ARG SER SEQRES 23 A 471 ILE TYR THR LEU ASN ASP GLY LEU SER ASP SER GLU ALA SEQRES 24 A 471 VAL ALA VAL GLY ARG TYR PRO GLU ASP SER TYR TYR ASN SEQRES 25 A 471 GLY ASN PRO TRP PHE LEU CYS THR LEU ALA ALA ALA GLU SEQRES 26 A 471 GLN LEU TYR ASP ALA LEU TYR GLN TRP ASP LYS GLN GLY SEQRES 27 A 471 SER LEU GLU ILE THR ASP VAL SER LEU ASP PHE PHE LYS SEQRES 28 A 471 ALA LEU TYR SER GLY ALA ALA THR GLY THR TYR SER SER SEQRES 29 A 471 SER SER SER THR TYR SER SER ILE VAL SER ALA VAL LYS SEQRES 30 A 471 THR PHE ALA ASP GLY PHE VAL SER ILE VAL GLU THR HIS SEQRES 31 A 471 ALA ALA SER ASN GLY SER LEU SER GLU GLN PHE ASP LYS SEQRES 32 A 471 SER ASP GLY ASP GLU LEU SER ALA ARG ASP LEU THR TRP SEQRES 33 A 471 SER TYR ALA ALA LEU LEU THR ALA ASN ASN ARG ARG ASN SEQRES 34 A 471 SER VAL VAL PRO PRO SER TRP GLY GLU THR SER ALA SER SEQRES 35 A 471 SER VAL PRO GLY THR CYS ALA ALA THR SER ALA SER GLY SEQRES 36 A 471 THR TYR SER SER VAL THR VAL THR SER TRP PRO SER ILE SEQRES 37 A 471 VAL ALA THR MODRES 1GAH ASN A 171 ASN GLYCOSYLATION SITE MODRES 1GAH ASN A 395 ASN GLYCOSYLATION SITE MODRES 1GAH SER A 443 SER GLYCOSYLATION SITE MODRES 1GAH SER A 444 SER GLYCOSYLATION SITE MODRES 1GAH SER A 453 SER GLYCOSYLATION SITE MODRES 1GAH THR A 457 THR GLYCOSYLATION SITE MODRES 1GAH SER A 459 SER GLYCOSYLATION SITE MODRES 1GAH SER A 460 SER GLYCOSYLATION SITE MODRES 1GAH THR A 462 THR GLYCOSYLATION SITE MODRES 1GAH THR A 464 THR GLYCOSYLATION SITE MODRES 1GAH THR A 452 THR GLYCOSYLATION SITE MODRES 1GAH SER A 455 SER GLYCOSYLATION SITE HET NAG B 1 27 HET NAG B 2 27 HET BMA B 3 21 HET MAN B 4 21 HET MAN B 5 22 HET NAG C 1 27 HET NAG C 2 27 HET BMA C 3 20 HET MAN C 4 21 HET MAN C 5 21 HET MAN C 6 22 HET MAN C 7 20 HET MAN C 8 22 HET MAN C 9 22 HET GLC D 1 46 HET GLC D 2 42 HET AC1 D 3 43 HET MAN A 473 44 HET MAN A 474 44 HET MAN A 475 22 HET MAN A 476 22 HET MAN A 477 22 HET MAN A 478 22 HET MAN A 479 22 HET MAN A 480 22 HET MAN A 481 22 HET MAN A 482 22 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM GLC ALPHA-D-GLUCOPYRANOSE HETNAM AC1 4,6-DIDEOXY-4-{[(1S,4R,5S,6S)-4,5,6-TRIHYDROXY-3- HETNAM 2 AC1 (HYDROXYMETHYL)CYCLOHEX-2-EN-1-YL]AMINO}-ALPHA-D- HETNAM 3 AC1 GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN GLC ALPHA-D-GLUCOSE; D-GLUCOSE; GLUCOSE HETSYN AC1 6-METHYL-5-(4,5,6-TRIHYDROXY-3-HYDROXYMETHYL-CYCLOHEX- HETSYN 2 AC1 2-ENYLAMINO)-TETRAHYDRO-PYRAN-2,3,4-TRIOL; 4,6- HETSYN 3 AC1 DIDEOXY-4-{[(1S,4R,5S,6S)-4,5,6-TRIHYDROXY-3- HETSYN 4 AC1 (HYDROXYMETHYL)CYCLOHEX-2-EN-1-YL]AMINO}-ALPHA-D- HETSYN 5 AC1 GLUCOSE; 4,6-DIDEOXY-4-{[(1S,4R,5S,6S)-4,5,6- HETSYN 6 AC1 TRIHYDROXY-3-(HYDROXYMETHYL)CYCLOHEX-2-EN-1-YL]AMINO}- HETSYN 7 AC1 D-GLUCOSE; 4,6-DIDEOXY-4-{[(1S,4R,5S,6S)-4,5,6- HETSYN 8 AC1 TRIHYDROXY-3-(HYDROXYMETHYL)CYCLOHEX-2-EN-1-YL]AMINO}- HETSYN 9 AC1 GLUCOSE FORMUL 2 NAG 4(C8 H15 N O6) FORMUL 2 BMA 2(C6 H12 O6) FORMUL 2 MAN 18(C6 H12 O6) FORMUL 4 GLC 2(C6 H12 O6) FORMUL 4 AC1 C13 H23 N O8 FORMUL 15 HOH *531(H2 O) HELIX 1 1 THR A 2 ASN A 21 1 20 HELIX 2 2 THR A 53 ARG A 68 1 16 HELIX 3 3 THR A 72 GLY A 90 5 19 HELIX 4 4 GLY A 103 GLY A 105 5 3 HELIX 5 5 ASP A 126 ASP A 144 1 19 HELIX 6 6 THR A 148 GLU A 153 1 6 HELIX 7 7 VAL A 155 TYR A 169 1 15 HELIX 8 8 PHE A 186 ALA A 205 1 20 HELIX 9 9 SER A 211 PHE A 227 1 17 HELIX 10 10 THR A 246 THR A 255 5 10 HELIX 11 11 PRO A 272 PHE A 285 1 14 HELIX 12 12 THR A 290 ASN A 292 5 3 HELIX 13 13 TYR A 311 ASN A 313 5 3 HELIX 14 14 PHE A 318 GLN A 338 1 21 HELIX 15 15 LEU A 348 LEU A 354 1 7 HELIX 16 16 SER A 368 HIS A 391 1 24 HELIX 17 17 THR A 416 ARG A 429 1 14 HELIX 18 18 GLU A 439 SER A 441 5 3 SHEET 1 A 2 SER A 340 ILE A 343 0 SHEET 2 A 2 GLY A 361 SER A 364 -1 N TYR A 363 O LEU A 341 SSBOND 1 CYS A 210 CYS A 213 1555 1555 2.03 SSBOND 2 CYS A 222 CYS A 449 1555 1555 2.02 SSBOND 3 CYS A 262 CYS A 270 1555 1555 2.04 LINK ND2 ASN A 171 C1 NAG B 1 1555 1555 1.46 LINK ND2 ASN A 395 C1 NAG C 1 1555 1555 1.44 LINK OG SER A 443 C1 MAN A 475 1555 1555 1.40 LINK OG SER A 444 C1 MAN A 476 1555 1555 1.40 LINK OG1ATHR A 452 C1 AMAN A 473 1555 1555 1.40 LINK OG1BTHR A 452 C1 BMAN A 473 1555 1555 1.40 LINK OG SER A 453 C1 MAN A 477 1555 1555 1.40 LINK OG ASER A 455 C1 AMAN A 474 1555 1555 1.39 LINK OG BSER A 455 C1 BMAN A 474 1555 1555 1.39 LINK OG1 THR A 457 C1 MAN A 478 1555 1555 1.40 LINK OG SER A 459 C1 MAN A 479 1555 1555 1.40 LINK OG SER A 460 C1 MAN A 480 1555 1555 1.40 LINK OG1 THR A 462 C1 MAN A 481 1555 1555 1.40 LINK OG1 THR A 464 C1 MAN A 482 1555 1555 1.41 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.38 LINK O4 NAG B 2 C1 BMA B 3 1555 1555 1.39 LINK O3 BMA B 3 C1 MAN B 4 1555 1555 1.41 LINK O2 MAN B 4 C1 MAN B 5 1555 1555 1.40 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.38 LINK O4 NAG C 2 C1 BMA C 3 1555 1555 1.37 LINK O3 BMA C 3 C1 MAN C 4 1555 1555 1.39 LINK O6 BMA C 3 C1 MAN C 7 1555 1555 1.39 LINK O2 MAN C 4 C1 MAN C 5 1555 1555 1.40 LINK O2 MAN C 5 C1 MAN C 6 1555 1555 1.40 LINK O3 MAN C 7 C1 MAN C 8 1555 1555 1.40 LINK O6 MAN C 7 C1 MAN C 9 1555 1555 1.40 LINK O4 AGLC D 1 C1 AGLC D 2 1555 1555 1.40 LINK O4 BGLC D 1 C1 BGLC D 2 1555 1555 1.40 LINK O4 AGLC D 2 C1 AC1 D 3 1555 1555 1.41 LINK O4 BGLC D 2 C1 AC1 D 3 1555 1555 1.41 CISPEP 1 GLY A 23 ALA A 24 0 0.50 CISPEP 2 ASN A 45 PRO A 46 0 -0.32 CISPEP 3 ARG A 122 PRO A 123 0 -0.15 SITE 1 SB1 7 ARG A 54 ASP A 55 LEU A 177 GLU A 179 SITE 2 SB1 7 ARG A 305 GLU A 400 HOH A 498 SITE 1 SB2 4 GLU A 180 TRP A 178 GLU A 179 ARG A 305 SITE 1 SB3 2 GLU A 179 GLY A 121 CRYST1 116.800 104.100 48.400 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008562 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009606 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020661 0.00000